clinical trial · NCT06818968
A Study of the Effect of Multiple Doses of Diltiazem on the Plasma Levels of MK-6916 in Healthy Participants (MK-6916-005)
Merck Sharp & Dohme LLC·phase1·completed·n = 37
HealthyMK-6916Diltiazem
brief summary
The goal of the study is to learn what happens to levels of MK-6916 in a healthy person's body over time. Researchers will compare what happens to MK-6916 in the body when it is given with or without another medicine called diltiazem.
started
Feb 27, 2025
primary completion
Aug 8, 2025
completion
Aug 8, 2025
last updated
Aug 26, 2025
official title
A 2-period, Fixed-sequence, Open-label Study to Evaluate the Effect of Multiple Oral Doses of Diltiazem on the Single-dose Pharmacokinetics of MK-6916 in Healthy Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol